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doi:10.1016/j.ejvs.2008.11.003Abstract Objective: To specifically compare the effect of two hydroxyethyl starches (HES)
on the splanchnic microcirculation and systemic inflammation during abdominal aortic aneu-
rysm (AAA) surgery.
Materials and methods: A prospective randomised study was carried out on 62 patients who
received HES of molecular-weight 200 kDa (HES200/0.62), 130 kDa (HES130/0.4) or gelatine
for 24 h peri-operatively. Gastric-mucosal pHi (GpHi) and anti-endotoxin antibody were used
as markers of splanchnic perfusion and endotoxaemia respectively. C-reactive protein (CRP)
and lung-injury score (LIS) were used as markers of systemic inflammation and end-organ
dysfunction respectively. Data was collected prospectively.
Results: The drop in GpHi was least with HES200/0.62 compared to HES130/0.4 and gelatine at
reperfusion (7.32 vs 7.28 and 7.28, pZ 0.017 and 0.009 respectively) and compared to gela-
tine at 2 h as well (7.43 vs 7.28, pZ 0.001). GpHi dropped less with HES130/0.4 compared
to gelatine at 2 h (7.39 vs 7.28, pZ 0.002). Endotoxaemia increased only with gelatine. CRP
was lower with HES200/0.62 (178 mg/mL) than gelatine (221 mg/mL) and HES130/0.4
(223 mg/mL) at 48 h (pZ 0.049 and pZ 0.009 respectively). There was no difference in LIS
but ventilation duration was less with HES200/0.62 compared with gelatine (4 vs 11 h,
pZ 0.012).
Conclusion: During AAA surgery, HES200/0.62 provides the best splanchnic microcirculation
protection, also reducing inflammation and duration of ventilation (Trial ISRCTN70166506).
ª 2008 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.86 1290260.
mail.com (A. Mahmood).
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Splanchnic mucosal hypoperfusion produces inflammatory
mediators that cause the systemic inflammatory response
during open infra-renal abdominal aortic aneurysm (AAA)
surgery.1e3 This in turn is associated with organ dysfunc-
tion.4,5 Splanchnic mucosal hypoperfusion during AAA
surgery occurs in both the large and small bowel leading to
portal and systemic endotoxin release and exacerbating
systemic inflammation that occurs also from lower limb
ischaemiaereperfusion injury.6e9 The pulmonary vascular
bed is usually the first to suffer from this inflammatory
response, leading to acute lung injury and non-cardiogenic
pulmonary oedema.
A growing body of work suggests that hydroxyethyl
starches (HES) have anti-inflammatory properties. HES with
ameanmolecular weight of 200 kDa (HES200/0.62) improves
splanchnic perfusion,3 attenuates the systemic inflamma-
tory response3 and reduces lung dysfunction10 when used as
a volume expander during AAA surgery. Different types of
HES preparations (HES200/0.62 and HES130/0.4) have been
shown to reduce renal injury during AAA repair.11
The specific aim of this study was to identify the optimal
HES solution that would improve splanchnic mucosal
perfusion and thereby reduce the release of gut derived
inflammatory mediators that contribute to systemic
inflammation.
We hypothesised that a HES solution with a smaller
number of high molecular weight molecules and thus
a more rheologically favourable profile (HES130/0.4)12
would provide better splanchnic mucosal perfusion and
thereby less systemic endotoxaemia, systemic inflamma-
tion and resultant lung injury than a HES solution with
a larger number of such molecules (HES200/0.62).
Methods
The study was approved by the South Birmingham ethics
committee and registered with Current Controlled Trials
(ISRCTN70166506). Patients were to be randomised to
receive either HES with a mean molecular weight of
200 kDa (HES200/0.62, Elohes), HES with a mean molecular
weight of 130 kDa (HES130/0.4, Voluven) (both HES solu-
tions are manufactured by Fresenius Kabi, Runcorn, UK) or
gelatine (Gelofusine, Braun, Sheffield, UK) for volume
expansion during surgery and for the first 24 h after surgery.
Patients undergoing elective open infra-renal AAA surgery
using a trans-peritoneal approach were included. Exclusion
criteria were patients with renal transplants, iliac occlusive
disease, a pre-operative serum creatinine of more than
177 mmol/L, left ventricular ejection fraction of less than
40% and juxta-renal aneurysms.
Study Design
Based on previous work from the same unit it was calcu-
lated that at least 20 patients would be required in each of
the 3 groups to show a significant difference of 40% in levels
of serum CRP at 5% level with a power of 80%.3 False
rejection of the null hypothesis was based on a power
calculation with alpha  100 set to 1.96 for 5% significance.This assumed a drop-out rate from mortality of 5% and
extreme values from re-operation of 10% in each group.
A smaller number of patients would be needed to show
similar differences in splanchnic perfusion and lung injury
score with any differences in endotoxaemia being explor-
atory. Randomisation was by blocks of 6 using a random
number table to allow equivalent numbers in each group.
Sealed envelopes allocating the fluid type were opened on
the morning of surgery. Recruitment, randomisation and
concealment were carried out by the trial co-ordinator. The
fluid regime and anaesthetic were standardised and have
been described previously.11 Patients were extubated on
return to the critical care unit when they were haemody-
namically stable with warm peripheries, normal acid-base
balance and good gas exchange. Blood loss was measured
by weighing swabs and volume of suction including losses on
return to theatre.
Measurement of Splanchnic Mucosal Perfusion
Gastric tonometry was used as a marker of splanchnic
mucosal perfusion as previously described.3 The gastric
tonometry TRIP catheter TONO-8F (Datex Ohmeda, Helsinki,
Finland) consists of a modified nasogastric tube and was
inserted after induction of anaesthesia. The tonometer
(Tonocap TC-200, DatexOhmeda, Helsinki, Finland) then fills
the balloon at the tip of the catheter with air and samples
mucosal CO2 levels using an infra-red sensor. Gastricmucosal
hypoperfusion increases the production of mucosal CO2 and
thus reduces gastric mucosal pHi (GpHi). Readings were
taken before the incision (pre-op1), just after start of
surgery (pre-op2), after cross clamp application, on clamp
removal and then at regular intervals until 24 h.
Measurement of Endotoxin Exposure
IgG EndoCab level measurement was used as a marker of
endotoxaemia with depletion occurring as a result of
increasing endotoxin levels. These assays were carried out
as previously described using commercially available ELISA
kits.6 Whole blood was sampled for endotoxin exposure pre-
operatively, after induction, at clamp application and then
at 12, 24, 48 and 72 h after clamp removal. The blood
samples were spun and the separated plasma immediately
frozen at 70 C for analysis later as a whole batch. To
ensure that any decrease in IgG EndoCab was not because
of capillary leak, the value was also expressed as a cor-
rected ratio in comparison with total serum IgG levels at
the same time points. The latter was measured using
a standard automated immunoturbidimetry technique.
Systemic Inflammatory Response
The serum C-reactive protein (CRP) was used as a marker of
the inflammatory response with whole blood samples taken
pre-operatively and then daily for 5 days.
Measurement of Pulmonary Dysfunction
The lung injury score was calculated on 3 criteria as
described by Murray et al.13 These were gas exchange, level
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x-ray at 4 h (maximum time of endothelial injury post-
operatively) after reperfusion. The sum was then divided by
3 to give the aggregate score. The duration of ventilation
was also recorded.
Statistical Analysis
Since patients returning to theatre or those with large
volume blood loss (>4 L during surgery) required changes to
the protocol for fluid infusion regime, both intention-to-
treat and per-protocol analyses were carried out based on
pre-study defined protocol violations. Per-protocol analysis
only included the time points until the protocol violation.
Data are presented as intention-to-treat. Normally distrib-
uted data are presented as means and standard deviation
with inter-group analysis carried out using ANOVA. Data not
distributed normally are presented as medians and inter-
quartile ranges with inter-group analysis using Kruskale
Wallis ANOVA. Changes from baseline were analysed using
the Friedman’s ANOVA. Categorical data were analysed
using the chi-squared test. A p-value of less than 0.05 was
taken to be statistically significant. The relationship
between gastric mucosal pHi, EndoCab and CRP was
explored by simple correlation of all the time-points. The
SPSS version 11 package was used for all analysis.
Results
Between April 2001 and February 2003, 80 consecutive
patients considered for abdominal aortic aneurysm surgery
were screened for the study of which 62 were randomised
(Fig. 1). Twenty-one received HES200/0.62, 21 received
HES130/0.4 and 20 had gelatine. The 3 groups were similar
in terms of demographics, pre-operative lung function,
operative details and fluid input (Table 1). There was no
difference in blood loss between the groups. All figures and
data shown are by intention-to-treat analysis.
Splanchnic Perfusion
There was a significant drop in gastric mucosal pHi (GpHi)
during surgery (Fig. 2) in all three groups with the lowest
levels recorded at clamp removal. The drop in GpHi was
least with HES200/0.62 compared to both HES130/0.4 and
gelatine at clamp removal (7.32 vs 7.28 and 7.28, pZ 0.017
and 0.009 respectively, KruskaleWallis test) and compared
to gelatine at 2 h as well (7.43 vs 7.28, pZ 0.001, Kruskale
Wallis test). GpHi also dropped less with HES130/0.4
compared to gelatine at 2 h (7.39 vs 7.28, pZ 0.002,
KruskaleWallis test).
Endotoxin Exposure
There was a significant decrease in EndoCab compared to
pre-operative levels in all 3 groups (Fig. 3). This drop was
less in the HES200/0.62 group compared to gelatine at 12 h
(51% vs 37%, pZ 0.003, KruskaleWallis test) with no
difference between HES130/0.4 and gelatine. There were
no significant changes in corrected EndoCab in either HES
group during surgery but a significant fall with gelatine(pZ 0.017, Friedman’s ANOVA, Fig. 4). Levels were also
significantly lower with gelatine compared with HES200/
0.62 at 12 h (116% vs 75%, pZ 0.006, KruskaleWallis test).
Systemic Inflammatory Response
Median serum C-reactive protein (CRP) increased signifi-
cantly in all 3 groups, peaking at 48 h (Fig. 5). Levels were
significantly lower in the HES200/0.62 group (178 mg/mL)
compared with both gelatine (221 mg/mL) and HES130/0.4
(223 mg/mL) at 48 h (Fig. 5, pZ 0.049 and pZ 0.009,
KruskaleWallis test, respectively). On per protocol anal-
ysis, levels were lower with HES200/0.62 compared to
gelatine (pZ 0.010, KruskaleWallis test) at 72 h as well.
Splanchnic mucosal hypoperfusion causing the release of
inflammatory mediators was demonstrated by the inverse
correlation between GpHi at 2 h and CRP at day 1
(rsZ 0.4, pZ 0.003) and day 2 (rsZ 0.31, pZ 0.030).
Pulmonary Dysfunction
The median lung injury score was 0.33 for the HES200/0.62
group, 0 in the HES130/0.4 group and 0.33 with gelatine
(Fig. 6) with no statistically significant difference between
the groups (pZ 0.33, KruskaleWallis ANOVA). The median
duration of post-operative invasive ventilation (Fig. 7) was
4 h with HES200/0.62, 8 h with HES130/0.4 and 11 h with
gelatine. This was significantly lower with HES200/0.62
compared with gelatine (pZ 0.012). There was no statis-
tically significant correlation between the splanchnic
perfusion markers and lung injury score.
Clinical Outcome
The 30-day mortality rate for the series was 11% (7/62). The
morbidities and causes of mortality are summarised in
Fig. 1. Two patients in the HES200/0.62 group developed
multi-organ failure after re-intervention for ischaemic
colitis and after intra-abdominal bleeding. Three patients
in the gelatine group developed multi-organ failure, 2 after
revascularisation for lower-limb ischaemia whilst in another
patient no cause was found. One patient in the HES130/0.4
group developed multi-organ failure after post-operative
intra-abdominal bleeding.
Discussion
This study has shown that two types of hydroxyethyl starch
solution (HES) differing primarily in mean molecular
weight, improve splanchnic perfusion and reduce endotoxin
exposure compared with gelatine during open infra-renal
AAA surgery. These findings are in agreement with work
examining the effect of HES on splanchnic perfusion in
other models of systemic inflammation including sepsis.14e16
This study has confirmed our previous findings illustrating
the superiority of HES200/0.62 over gelatine in the
splanchnic microcirculation and also demonstrates for the
first time the importance of the relationship between
better splanchnic mucosal perfusion by different types of
HES solutions and prevention of endotoxaemia.3 In addi-
tion, these novel data show that HES200/0.62 has a more
HES200/0.62
N=21
HES130/0.4
N=21
GELATINE
N=20
N=2 re-laparotomy for bleeding 
N=1 re-laparotomy for colitis (died)
N=1 embolectomy post-operatively
N=1 intra-operative bleeding 
N=1 re-laparotomy for
bleeding  
N=1 cardiac event (died)
N=2 bypasses (died)
N=1 acute renal failure
(died)
N=2 cardiac events (died)
N=1 primary MOF (died)
N=21 patients
analysed
N=80 patients screened
N=9 patients unfit for surgery
N=4 patients EVAR
N=1 patient juxta-renal AAA
N=3 patients iliac occlusion
N=1 patient declined participation
62 patients randomised
N=21 patients
analysed
N=20 patients
analysed
Figure 1 Study flow through and CONSORT diagram. EVAR, endovascular abdominal aortic aneurysm repair; MOF, multi-organ
failure.
322 A. Mahmood et al.favourable effect on splanchnic mucosal perfusion and
systemic inflammation during AAA surgery than HES130/0.4.
This however is in disagreement with one previous study in
which splanchnic mucosal perfusion was better with gela-
tine compared to HES in septic patients.17 A major omission
from that study was the volume of crystalloid administered.
The latter is extremely important since starches require
adjuvant crystalloid infusion to prevent hyperosmolar
damage to cells.
The findings go against our working hypothesis that
HES130/0.4 would be superior to HES200/0.62 in
improving blood flow and splanchnic perfusion and hence
would reduce systemic inflammation. On the contrary,
HES200/0.62 proved to be better than HES130/0.4.
A possible explanation is the prevention of trans-capillary
escape of albumin through activated endothelium by HES
macromolecules and therefore better retention of fluid inthe intravascular space for maintenance of splanchnic
perfusion.18,19 This biophysical explanation is however
unlikely since HES130/0.4 contains a greater concentra-
tion of appropriately sized molecules to produce such an
effect. The more plausible explanation would be reduced
endothelial activation in the splanchnic microcirculation
by HES200/0.62 which is consistent with experimental
and clinical work.20e22 The protective effect of both
types of HES on splanchnic perfusion being observed only
after the onset of systemic inflammation at clamp
removal supports an argument in favour of a more active
effect at the level of the splanchnic endothelium, rather
than better intrinsic properties of the fluids in improving
haemorheology.
Although there was a clear difference in splanchnic
perfusion and systemic inflammation between the 2 types
of HES, there was no difference in levels of endotoxin
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Figure 2 Splanchnic mucosal perfusion. Higher GpHi indi-
cates better perfusion. *p < 0.05 HES200/0.62 vs gelatine,
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Hydroxyethyl Starches and Systemic Inflammation 323exposure. Reasons for this include an anti-inflammatory
effect on other parts of the inflammatory cascade or a type
II error because of the exploratory nature of the endotoxin
analysis. The latter explanation is more likely as there was
a significant inverse correlation between gastric mucosal
pHi and serum C-reactive protein levels.
Gut derived inflammatory mediators such as endotoxin
and IL-6, a major contributor to the synthesis of C-reactiveTable 1 Patient demographics, operative details and fluid infu
HES200/0.62 (nZ 21) H
Demographics
Age (years)a 72 (7) 7
Sex (M:F) 16:5 1
BMI (kg/m2)a 26 (4) 2
Ejection fraction (%) 55 (49e65) 5
Aneurysm diameter (cm)a 6.1 (0.1) 6
Pre-operative Hb(g/dL)a 13.7 (1.7) 1
FEV1 (L)
a 1.97 (0.78) 2
FVC (L)a 2.89 (0.97) 3
Anti-platelet agents 8 2
B-blockers 1 5
Statins 5 9
Operative details
Type of graft (straight) 10 1
Procedure time (min) 155(135e195) 1
Clamp duration (min) 60 (43e83) 5
Intra-operative inotropes 4 6
Post-operative inotropes 5 9
Fluid input/loss
Volume of colloid (ml)a 3443 (1769) 3
Volume of crystalloid (mL) 5590 (4845e6325) 5
Blood transfusion (units) 7 (4.5e10) 6
Blood loss (mL) 1500 (1055e2050) 1
BMI, body mass index; Hb, haemoglobin; M, male; F, female; FEV1, fo
a Mean and standard deviation (normally distributed).protein are known to contribute to lung injury. Our data
however did not show better lung function with HES200/
0.62 unlike the previous study comparing HES200/0.62 and
gelatine in aortic aneurysm surgery.10 This may in part be
from a type II error because of a greater number of
protocol violations in the HES200/0.62 group than envis-
aged when carrying out the power calculation. In addition,
unlike our previous study, normal saline was used rathersion and loss
ES130/0.4 (nZ 21) Gelatine (nZ 20) p-value
2 (7) 73 (8) 0.710
9:2 15:5 0.250
6 (6) 26 (5) 0.940
0 (40e52) 55 (50e60) 0.110
.1 (0.4) 6.1 (0.4) 0.920
3.6 (2.0) 12.8 (2.2) 0.460
.10 (0.93) 1.76 (0.72) 0.540
.30 (0.90) 2.50 (0.94) 0.070
8 0.920
3 0.220
4 0.220
4 13 0.380
50 (135e233) 170 (124e244) 0.746
5 (45e65) 60 (40e73) 0.990
3 0.680
5 0.550
911 (1783) 4490 (1499) 0.150
750 (5110e6695) 4975 (4203e5565) 0.010
(4e8) 7 (5.25e9.75) 0.360
650 (1025e2630) 1700 (800e3150) 0.760
rced expired volume in 1 s; FVC, forced vital capacity.
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324 A. Mahmood et al.than Ringer’s lactate as the crystalloid fluid. The former
has a greater concentration of sodium and therefore its
use may have over-ridden any protective effects by
HES200/0.62 on the pulmonary microcirculation by
increasing fluid flux into lung tissue. The former explana-
tion however is more likely since the lung injury score was
similar for HES200/0.62 in both studies.10 Nevertheless,
despite a greater number of surgical complications the
total duration of ventilation was significantly less with
HES200/0.62 compared to gelatine suggesting a quicker
return to normal homeostasis.Serum C-Reactive Protein
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mortality rate, small differences in measured outcomes and
risk of type I error from repeated measures. The mortality
rate may be because of either a high re-intervention rate or
lack of institution of best medical therapy, therefore ques-
tioning the clinical applicability of the results. However, this
study never intended to change clinical practice in the types
of volume expansion used during AAA surgery but merely to
identify optimal HES solutions that may protect the
splanchnic and pulmonary microcirculation. Although theD
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Figure 7 Duration of invasive ventilation.
Hydroxyethyl Starches and Systemic Inflammation 325magnitude of the differences was small, the study was not
designed to show clinically significant differences but to
identify optimal types of commonly used colloids for the
purpose of designing future trials assessing clinical outcome.
Nevertheless, gastric mucosal pHi dropped to less than 7.32
only in the HES130/0.4 and gelatine groups, a cut-off value
associated with a higher risk of complications.23
This study provides additional knowledge into possible
mechanisms of anti-inflammatory effects by HES macro-
molecules, already shown to reduce inflammation in other
clinical models of systemic inflammatory response including
major trauma and sepsis.15,16,24 One can conclude that
although differing types of HES improve splanchnic perfu-
sion during AAA surgery compared with gelatine, all types
of HES are not the same. A greater effect was observed with
HES200/0.62 which also reduced systemic inflammatory
response and duration of invasive ventilation.
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